Mangalam Drugs & Organics Limited (NSE:MANGALAM)

India flag India · Delayed Price · Currency is INR
30.03
-0.08 (-0.27%)
Jun 19, 2026, 3:30 PM IST
Market Cap477.22M -61.8%
Revenue (ttm)2.32B -26.9%
Net Income-444.00M
EPS-28.05
Shares Out n/a
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume29,416
Open30.50
Previous Close30.11
Day's Range29.20 - 30.50
52-Week Range22.80 - 95.00
Beta0.11
AnalystsStrong Buy
Price Target265.00 (+782.45%)
Earnings DateAug 10, 2026

About Mangalam Drugs & Organics

Mangalam Drugs & Organics Limited, together with its subsidiary, manufactures and sells active pharmaceutical ingredients (APIs) and intermediates in India. The company offers active pharmaceutical ingredients (API) products, including acyclovir, amodiaquine, artemether, artesunate, bisoprolol fumarate, chloroquine phosphate, dihydroartemisinin, dolutegravir sodium, efavirenz, emtricitabine, etodolac, furosemide, hydroxychloroquine sulphate, lumefantrine, nimesulide, nitrofurantoin anhydrous and monohydrate, olanzapine, primaquine and piperaqui... [Read more]

Sector Healthcare
Founded 1972
Employees 480
Stock Exchange National Stock Exchange of India
Ticker Symbol MANGALAM
Full Company Profile

Financial Performance

Financial Statements